Managed Healthcare Executive16h
FDA Approves Gomekli, First and Only NF1-PN Treatment for Both Children and Adults
Gomekli is the second ever FDA-approved treatment for rare tumor disease, NF1-PN and the first to be approved for both adult ...
Pharmaceutical Technology3d
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
manilatimes3d
SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric ...
Cuba Headlines7d
Damir's Determined Fight for a Humanitarian Visa Amid Hospital Hurdles
Ten-year-old Damir Ortiz Ramírez, a Cuban child, is battling serious health issues while his family, alongside several activists, tirelessly pursues ...
Cuba Headlines8d
U.S. Denies Humanitarian Visa to Cuban Child Damir Due to MINSAP Bureaucracy
The U.S. Embassy in Havana has refused a humanitarian visa for Damir Ortiz Ramírez, a 10-year-old Cuban boy suffering from ...